#oncopeptides — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #oncopeptides, aggregated by home.social.
-
Oncopeptides Announces Rights Issue
Oncopeptides executes a rights issue of approx SEK 200 million. Proceeds will support Pepaxti commercialization in Europe and advance the glioblastoma project to clinical development, including a window-of-opportunity study. HealthCap VIII LP commits SEK 20 million.
-
Oncopeptides Announces Rights Issue
Oncopeptides executes a rights issue of approx SEK 200 million. Proceeds will support Pepaxti commercialization in Europe and advance the glioblastoma project to clinical development, including a window-of-opportunity study. HealthCap VIII LP commits SEK 20 million.
-
Oncopeptides Announces Rights Issue
Oncopeptides executes a rights issue of approx SEK 200 million. Proceeds will support Pepaxti commercialization in Europe and advance the glioblastoma project to clinical development, including a window-of-opportunity study. HealthCap VIII LP commits SEK 20 million.
-
Oncopeptides Announces Rights Issue
Oncopeptides executes a rights issue of approx SEK 200 million. Proceeds will support Pepaxti commercialization in Europe and advance the glioblastoma project to clinical development, including a window-of-opportunity study. HealthCap VIII LP commits SEK 20 million.
-
Oncopeptides Announces Rights Issue
Oncopeptides executes a rights issue of approx SEK 200 million. Proceeds will support Pepaxti commercialization in Europe and advance the glioblastoma project to clinical development, including a window-of-opportunity study. HealthCap VIII LP commits SEK 20 million.